Fred Aslan Insider Profile
11 Followers
Fred Aslan, CEO, Director at Artiva Biotherapeutics, Inc., holds 1.45M shares in Artiva Biotherapeutics, Inc. (Ticker: ARTV).
Fred Aslan Artiva Biotherapeutics, Inc. (ARTV)CEO, Director
Artiva Biotherapeutics, Inc. (ARTV)
CEO, Director
Ranked #69,037 out of 108,921 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-15.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Fred Aslan holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Sep 04, 2026 - Today
Return:0.00%
The most profitable trade made by Fred Aslan
Fred Aslan's Trading History
List of latest transactions for each holding click on a transaction to see Fred Aslan's performance on stock
You May Also Like
Fred Aslan insider profile FAQ
What is the percentage of profitable transactions made by Fred Aslan?
The percentage of profitable transactions made by Fred Aslan is 0%.
What is the average return per transaction made by Fred Aslan?
The average return per transaction made by Fred Aslan is -15.40%.
What stocks does Fred Aslan hold?
Fred Aslan holds: ARTV stocks.
What was Fred Aslan’s latest transaction?
Fred Aslan latest transaction was an Uninformative Sell of $255.61K.
What was Fred Aslan's most profitable transaction?
Fred Aslan’s most profitable transaction was an Informative Sell of ARTV stock on September 4, 2026. The return on the trade was 0.00%.
What is Fred Aslan's role in Artiva Biotherapeutics, Inc.?
Fred Aslan's role in Artiva Biotherapeutics, Inc. is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.